Metaplastic breast carcinoma
series of cases and literature review
Keywords:
triple negative breast neoplasms, breast, neoplasms, review, neoplasms by histological type, treatment outcomeAbstract
Introduction: Metaplastic breast carcinoma is a heterogeneous group of infrequent invasive carcinomas with aggressive behavior. It presents differentiation from the neoplastic ductal epithelium to squamous and/or sarcomatous mesenchymal component, through the epithelial-mesenchymal transition process, and may present morphology of epithelioid and fusiform cells, with possible cartilage, bone, lipomatous, fibromatous, smooth muscle or skeletal muscle differentiation, among others. Most of the cases present the triple-negative immunohistochemical profile. Objective: To report three cases of metaplastic carcinomas, with an emphasis on clinical and pathological aspects, in addition to conducting a literature review on this topic. Methods:The three cases were registered in the internal search system for reference services in breast pathology in São Paulo, between 2012 and 2019. For literature review, the keywords metaplastic carcinoma, breast, cancer, review, breast cancer subtype and pathological and clinical outcomes were used in PubMed. We found 154 articles, of which 42 were selected for full reading, based on the abstract and established inclusion criteria. After this initial selection, these articles were read and reviewed; nine articles that did not meet the inclusion criteria were excluded. Discussion: Three cases of metaplastic carcinoma with similar immunohistochemical characteristics have been reported. The first case is that of a 40-year-old patient with the diagnosis of metaplastic carcinoma producing a chondroid matrix with liposarcomatous and osteosarcomatous differentiation. The second case is that of a 50-year-old patient who presented with the final diagnosis for a fusocellular metaplastic carcinoma with lymph node metastasis. Finally, the third case described is that of a 59-year-old patient, who presented metaplastic carcinoma with chondroid differentiation. Conclusion: Metaplastic carcinoma is a rare and aggressive type of breast cancer, in which most of the patients have shorter survival and worse prognosis in relation to the other subtypes. More studies are needed in order to determine a gold standard treatment for this disease.
Downloads
References
Reis-Filho JS, Gobbi H, McCart Reed AE, Rakha EA, Shin SJ, Sortiriou C, et al. WHO classification of tumours: breast tumours. 5ª ed. Geneva: WHO; 2020.
Lakhani SR, International Agency for Research on Cancer, World Health Organization. WHO classification of tumours of the breast: views of a working group that convened for a consensus and editorial meeting at the International Agency for Research on Cancer (IARC), Lyon, September 1 - 3, 2011. 4. ed. Lyon: Agency for Research on Cancer; 2012. 240 p.
Han M, Salamat A, Zhu L, Zhang H, Clark BZ, Dabbs DJ, et al. Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy. Mod Pathol. 2019;32(6):807-16. https://doi.org/10.1038/s41379-019-0208-x
El Zein D, Hughes M, Kumar S, Peng X, Oyasiji T, Jabbour H, et al. Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a study from a single institution and review of literature. Clin Breast Cancer. 2017;17(5):382-91. https://doi.org/10.1016/j.clbc.2017.04.009
McKinnon E, Xiao P. Metaplastic carcinoma of the breast. Arch Pathol Lab Med. 2015;139(6):819-22. https://doi.org/10.5858/arpa.2013-0358-rs
Shin HJ, Kim HH, Kim SM, Kim DB, Kim M-J, Gong G, et al. Imaging features of metaplastic carcinoma with chondroid differentiation of the breast. Am J Roentgenol. 2007;188(3):691-
https://doi.org/10.2214/ajr.05.0831
Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10(16):5367-74. https://doi.org/10.1158/1078-0432.ccr-04-0220
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Brasil: estimativas de novos casos. Brasil: Ministério da Saúde; 2020.
Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893-917. https://doi.org/10.1002/ijc.25516
Sarturi PR, Cunha-Junior AD, Morais CF. Perfil imunohistoquímico do câncer de mama de pacientes atendidas no hospital de câncer Cascavel - Paraná. Rev Bras Oncol Clín. 2012;8(29):121-4.
Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci. 2003;100(14):8418-23. https://doi.org/10.1073/pnas.0932692100
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492-502. https://doi.org/10.1001/jama.295.21.2492
Cirqueira MB, Moreira MAR, Soares LR, Freitas-Júnior R. Subtipos moleculares do câncer de mama. Femina. 2011;39(10):499-503.
Russnes HG, Vollan HKM, Lingjaerde OC, Krasnitz A, Lundin P, Naume B, et al. Genomic architecture characterizes tumor progression paths and fate in breast cancer patients. Sci Transl Med. 2010;2(38):38ra47. https://doi.org/10.1126/scitranslmed.3000611
Sørlie T. Molecular classification of breast tumors: toward improved diagnostics and treatments. Methods Mol Biol. 2007;360:91-114. In: Target Discovery and Validation Reviews and Protocols. New Jersey: Humana Press; 2006. p. 91-114. https://doi.org/10.1385/1-59745-165-7:91
Kwei KA, Kung Y, Salari K, Holcomb IN, Pollack JR. Genomic instability in breast cancer: Pathogenesis and clinical implications. Mol Oncol. 2010;4(3):255-66. https://doi.org/10.1016/j.molonc.2010.04.001
Rungta S, Kleer CG. Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights. Arch Pathol Lab Med. 2012;136(8):896-900. https://doi.org/10.5858/arpa.2012-0166-cr
Abd El-All HS. Breast spindle cell tumours: about eight cases. Diagn Pathol. 2006;1:13. https://doi.org/10.1186/1746-1596-1-13
Chu Z, Lin H, Liang X, Huang R, Zhan Q, Jiang J, et al. Clinicopathologic characteristics of typical medullary breast carcinoma: a retrospective study of 117 cases. PLoS One. 2014;9(11):e111493. https://doi.org/10.1371/journal.pone.0111493
Moten AS, Jayarajan SN, Willis AI. Spindle cell carcinoma of the breast: a comprehensive analysis. Am J Surg. 2016;211(4):716-21. https://doi.org/10.1016/j.amjsurg.2015.11.023
Cho SN, Kim YS, Kim KC. Very rare case of spindle cell carcinoma of breast in male. J Breast Dis. 2014;2(2):69-72. https://doi.org/10.14449/jbd.2014.2.69
Ünal B, Erdoğan G, Karaveli FŞ. Step by step approach to rare breast lesions containing spindle cells. Springerplus. 2015;4:678. https://doi.org/10.1186/s40064-015-1480-y
Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol. 2004;28(11):1506-12. https://doi.org/10.1097/01. pas.0000138183.97366.fd
Zhu H, Li K, Dong D, Fu J, Liu D, Wang L, et al. Spindle cell metaplastic carcinoma of breast: a clinicopathological and immunohistochemical analysis: histopathology of SpCMC. Asia Pac J Clin Oncol. 2017;13(2):e72-8. https://doi.org/10.1111/ajco.12322
Song Y, Liu X, Zhang G, Song H, Ren Y, He X, et al. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol. 2013;11:129. https://dx.doi.org/10.1186%2F1477-7819-11-129
Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC. Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies. Exp Hematol Oncol. 2013;2(1):31. https://doi.org/10.1186/2162-3619-2-31
Edenfield J, Schammel C, Collins J, Schammel D, Edenfield WJ. Metaplastic breast cancer: molecular typing and identification of potential targeted therapies at a single institution. Clin Breast Cancer. 2017;17(1):e1-10. https://doi.org/10.1016/j.clbc.2016.07.004
Kim Y-J, Shim H-S, Lee H, Jung W-H. Metaplastic carcinoma with extensive chondroid differentiation in the breast (chondroid carcinoma). Yonsei Med J. 2006;47(2):259-63. https://dx.doi.org/10.3349%2Fymj.2006.47.2.259
Foulkes WD, Stefansson IM, Chappuis PO, Bégin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst. 2003;95(19):1482-5. https://doi.org/10.1093/jnci/djg050
Gwin K, Wheeler DT, Bossuyt V, Tavassoli FA. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER−, PR−, Her2/neu−) cases. Int J Surg Pathol. 2010;18(1):27-35. https://doi.org/10.1177/1066896909332732
McMullen ER, Zoumberos NA, Kleer CG. Metaplastic breast carcinoma: update on histopathology and molecular alterations. Arch Pathol Lab Med. 2019;143(12):1492-6. https://doi.org/10.5858/arpa.2019-0396-ra
Khan HN, Wyld L, Dunne B, Lee AHS, Pinder SE, Evans AJ, et al. Spindle cell carcinoma of the breast: a case series of a rare histological subtype. Eur J Surg Oncol. 2003;29(7):600-3. https://doi.org/10.1016/s0748-7983(03)00107-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Giulia Papa, Carolina Fernanda Ferreira, Luisa Damasio, Karla Calaça Kabbach Prigenzi
This work is licensed under a Creative Commons Attribution 4.0 International License.
